Clinical Trial Update: AR-12286 in Combination With Latanoprost [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AR-12286 in combination with latanoprost for glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• AR-12286
• Latanoprost (Latanoprost)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED